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A sudden increase in the incidence of scrapie in Italy in 1997 was subsequently linked to the use of a potentially
infected vaccine against contagious agalactia. The relative risk for the exposed farms ranged between 6 and 40. The
aim of this study was to assess the long-term impact of exposure to the potentially scrapie-contaminated vaccine
on the Italian classical scrapie epidemic. We carried out a retrospective cohort study, fitting mixed-effects Poisson
regression models, dividing national geographic areas into exposure categories on the basis of the vaccine
circulation levels. We took into account the sensitivity of the surveillance system applied in the different areas. The
population attributable fraction (PAF) was used to assess the impact on the total population of farms associated
with the effect of circulation of the vaccine. The provinces where the vaccine was more often sold were noted to
have a higher level of disease when compared to those provinces where the vaccine was sold less often (incidence
rate ratio [IRR]: 2.7; 95% confidence interval [CI]: 1.1-6.5). The population attributable fraction was high (68.4%).
Standardization techniques allowed to account for the potential of geographical variability in the sensitivity of the
Italian surveillance system. Although the number of the directly exposed farms was limited, an important long-term
impact of the vaccine circulation could be quantified in terms of secondary outbreaks likely due to the exchange of
animals from directly exposed flocks.Introduction
A sudden increase in the incidence of scrapie in Italy in
1997 was subsequently linked to the administration of a
potentially infected vaccine against contagious agalactia.
The commonly known risk factors for scrapie are the
prion protein genotype and flock management practices
such as movement of animals, sharing pastures with
other flocks, and flock size [1-13]. As the epidemic
unfolded, the large number of cases, the temporal clus-
tering of the outbreaks, the exceptional involvement of
goats, a species in which scrapie is rarely reported, the
high in-flock incidence and the recurring reporting of
exposure to a unique vaccine in many outbreaks all* Correspondence: silvia.bertolini@izsto.it
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reproduction in any medium, provided the orpointed to an accidental infection [14]. This hypothesis
was consistent with Gordon’s description (1946) of a
similar episode that had occurred in Scotland in 1937
when a sudden epidemic peak of scrapie was associated
with the circulation of a vaccine against Louping ill. The
investigations led to a vaccine batch that had been pro-
duced from the nervous tissue of lambs affected by scra-
pie in the incubative stage of the infection [15].
In the Italian accident, the vaccine was a formol-
inactivated immunogen against contagious agalactia pre-
pared by a single manufacturer (Rome, Italy) from the
brain and mammary gland homogenates of sheep experi-
mentally infected with Mycoplasma agalactiae [14,16].
The vaccine was distributed between November
1994 and December 1996 in eight regions of central
and southern Italy where flocks currently number about
78 000.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that the relative risk for the exposed farms versus the
farms where the animals had not been administered the
vaccine ranged between 6 and 40. However, the impact
on the general population in terms of proportion of dis-
ease attributable to exposure was limited, probably be-
cause of the limited number of the farms that
were directly exposed [17]. The effect the circulation of
a potentially infected vaccine may have on the onset of
secondary outbreaks and its effect in terms of population
impact can be quantified by analysing long-term
data series.
In European countries the passive surveillance system
for scrapie has been integrated since 2002 with an active
surveillance program targeting samples of the sheep and
goat populations older than 18 months of age. Animals
are identified within different risk streams, i.e., as
healthy animals at abattoir or fallen stock, and are sub-
mitted to the so-called rapid tests for the detection of
abnormal PrP in the brainstem. The probability of case
detection (i.e., surveillance sensitivity) is highest among
fallen stock and increases with the number of animals
tested per flock [18-21]. Accordingly, standardized inci-
dence data adjusted for surveillance sensitivity at the
provincial level are needed in order to make unbiased
geographical comparisons.
The application of surveillance systems with geograph-
ical heterogeneous sensitivity may lead to different prob-
abilities to detect the disease. Observed incidence rates
or prevalence data don't take these differences into ac-
count and could be misleading when making geograph-
ical comparisons.
The aim of this study was to assess the long-term im-
pact of exposure to a potentially scrapie-contaminated
vaccine on the Italian classical scrapie epidemic. We car-
ried out a retrospective cohort study, dividing national
geographic areas into exposure categories on the basis of
the vaccine circulation levels. We compared the disease
frequency in the subsequent years in each of the expos-
ure categories, taking into account the sensitivity of the
surveillance system applied.
In this way we were able to identify an association be-
tween the surveillance-adjusted incidence level of the
disease and the diffusion of the vaccine even long after
direct exposure. Also, we were able to quantify the im-
pact in terms of percentage of outbreaks attributable to




The analysis focused on the eight regions of central and
southern Italy where the vaccine had been distributed
(Tuscany, Lazio, Campania, Apulia, Basilicata, Calabria,Sicily and Sardinia). The vaccine had been reportedly
used in 29 out of 45 provinces in these regions.
Databases
The data from three different datasets were analysed: na-
tional surveillance data, vaccine distribution data and
National Animal Registry Office data.
National Surveillance data
We used data from the Small Ruminant TSE national
database maintained by the Reference Centre for Animal
Encephalopathy at IZSPLVA.
Data from active surveillance for scrapie in sheep and
goats in the study area from 1 January 2002 to 31
December 2005a were considered because we assumed
that data from later years could conceal the potential ef-
fect of the vaccine. This dataset comprised data from 95
714 animals tested in the surveillance stream of regularly
slaughtered animals and from 11 757 animals tested in
the fallen stock stream, thus recruiting a total of 16 755
flocks for the study. These data were then aggregated at
the flock level to obtain the number of animals tested
per holding in the two surveillance streams. County, par-
ish, and holding (CPH) identifiers were used to identify
each flock.
We then used the data on the 50 outbreaks of classical
scrapie in sheep and 7 outbreaks in goats identified by
active surveillance on fallen stock and regularly slaugh-
tered animals in the study area during the same period.
Vaccine distribution data
A list was obtained of the 177 flock farmers who had
bought the formol inactivated vaccine against contagious
agalactia between November 1994 and December 1996.
This period is consistent with the higher risk of contam-
ination of the vaccine according to the information pro-
vided by the vaccine manufacturer. Although brain
homogenates of sheep infected with Mycoplasma agalac-
tiae were no longer used as an ingredient in the vaccine,
its production continued up to July 1997. Not all the po-
tentially exposed flocks could be traced back, however,
because in some cases the list included only the name of
a veterinarian or a retailer instead of the flock farmer’s
name. To fill this gap, we compiled a list of 29 veterinar-
ians or retailers who had purchased the vaccine as own
stock during the period in question. Data from the two
lists were aggregated to provide provincial level data.
National Animal Registry Office data
We considered the number of farms registered within
the National Animal Registry Office for each province.
In order to obtain a more reliable size of the susceptible
population we decided to use the average number of
farms in operation in the 8 regions (78 463 farms)
Table 1 Distribution of Italian farms of small ruminants




















1 1 1 131 893
2 1 2 1157
3 1 3 585
4 2 1 2884
5 2 2 101
6 2 3 74
7 3 1 1862
8 3 2 75
9 3 3 90
This distribution was used as external standard population to calculate the
standardized incidence rates. For both variables, the classes were created on
the basis of the distribution of number of farms (level 1: 75% of farms; level 2:
15% of farms; level 3: 10% of farms. Additionally, the farms where no regularly
slaughtered or fallen stock animals had been tested were respectively
included into level 1).
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cation and registration system that went into effect at
the national level in 2005.
Statistical analysis
Stata Software 11.1 (Stata Corp, College Station, TX)
was used to create the databases and process the data
for the statistical analysis. The ArcGIS version 9.2 (ESRI,
Redlands, CA, USA) was used to create the thematic
maps.
In this retrospective cohort study the incidence rates
for each province for the entire study period were calcu-
lated as the ratio of the number of new outbreaks
observed per 1000 registered farms.
Direct standardization techniques [23,24] were applied
to adjust for surveillance sensitivity in the eight pro-
vinces. The incidence rates, standardized on the applied
surveillance, allow to obtain the distribution of the dis-
ease as if the surveillance was uniformly applied
throughout the entire area. We used the dstdize com-
mand (Stata).
The total number of farms registered with the Na-
tional Animal Registry Office in the 108 Italian pro-
vinces (n= 138 721) was used as external standard
population, from which nine levels of surveillance sensi-
tivity were created based on both the surveillance stream
(regularly slaughtered and fallen stock categories) and
the categorization of the number of animals tested by
stream on each farm.
Within each surveillance stream we defined three sen-
sitivity levels: for the regularly-slaughtered category, a
level of 1, 2 or 3 was applied when 1 to 5 (75% of farms),
6 to 12 (15% of farms) or 13 or more animals (10% of
farms), respectively, had been tested. Additionally, the
farms where no regularly-slaughtered animals had been
tested were included into level 1, accounting for the pro-
portion of farms never involved by active surveillance.
For the fallen stock stream, the respective intervals were
1 to 2 (75% of farms), 3 to 5 (15% of farms), and 6 or
more animals (10% of farms); again, the farms where no
fallen stock animals had been tested were included into
level 1. Table 1 illustrates the scheme of the various
combinations.
Most of the total number of the farms (95.08% of the
138 721 registered farms) were categorized as global sur-
veillance sensitivity level 1.
To estimate the association between vaccine exposure
and disease levels for each province, we carried out a
preliminary univariate analysis based on Poisson models,
wherein the relative risks were computed to obtain the
incidence rate ratios. In order to consider the herd size
as a possible confounder we included the median of the
herd size for each province in this analysis. We then fit-
ted mixed-effects Poisson regression models includingthe variables that resulted as having a health impact
from the univariate analysis. We used a xtpoisson com-
mand (Stata) because in this function a gamma distribu-
tion with mean 1 and variance alpha is assumed for the
level-2 random intercept, to account for a possible
within-cluster dependence (i.e. overdispersion) [25].
The number of farms in a given province that had pur-
chased the vaccine was used to define an explanatory vari-
able to quantify the vaccine circulation. In a first model,
the number of the observed outbreaks for each province
was entered as a dependent variable to assess the role of
exposure to vaccine. The number of registered flocks in
each province was considered as offset. Region was
included as a random-effect variable.
To investigate the potential role of the vaccine due to
its distribution through veterinarians or retailers, a cat-
egorical variable based on the number of veterinarians
or retailers who had purchased the vaccine as own stock
in each province was subsequently added as a covariate.
On the basis of the number of farms which had
bought the vaccine, three exposure levels (ELfarm) were
defined: (1) provinces where 0–4 farms bought the vac-
cine (66.7% of provinces); (2) provinces where 5–10
farms bought the vaccine (20.0% of provinces); (3) pro-
vinces where > 10 farms bought the vaccine (13.3% of
provinces). For the variable based on the number of
veterinarians or retailers, two exposure levels (ELvet)
were defined: (1) provinces where 0–1 veterinarian or
retailer bought the vaccine (86.7% of provinces); (2)
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vaccine (13.3% of provinces).
The Akaike Information Criterion (AIC) was applied
to compare the models including and not including each
explanatory variable and to compare the mixed- and
fixed-effect models [26]. These models were then fitted
using standardized incidence rates adjusted for surveil-
lance sensitivity based on the data shown in Table 1.
The number of expected outbreaks for each province
constituted the dependent variable obtained by mul-
tiplying the standardized rates by the number of
registered farms.
The statistical significance of a linear dose-response
trend of the number of farms which had bought the vac-
cine (exposure level) with respect to the disease inci-
dence level was tested using the Wald test to verify the
statistical significance of the linear regression coefficient
of the vaccine circulation variable entered as a continu-
ous variable in all four models [27,28].
Finally, the population attributable fraction (PAF) was
used to assess the impact on the total population of
farms associated with the circulation of the vaccine. PAF
is the proportion of disease among the total population
that would be eliminated if the exposure were eliminated
[29]. In this case, we applied the formula suggested by
Rockhill because we had multicategory exposures and
the presence of confounding using model 3 results on













pdi is the proportion of total cases in the population
arising from the ith exposure category;
RRi is the adjusted relative risk for the ith exposure
category (relative to the unexposed stratum).
Graphic representation
The distribution of exposure to the vaccine and the dis-
tribution of disease in the province where the vaccine
had been distributed are shown in thematic maps. The
maps were generated from the number of farms that had
purchased the vaccine and the standardized rates for
each of the 45 provinces.
Results
Twenty-five provinces of the 8 regions where the vaccine
had been distributed experienced at least one scrapie
outbreak. The range of variability of the 4-year standar-
dized incidence rates (2002–2005) for the 25 provinces
was 0.20 to 5.8 outbreaks/1000 farms, with ≤ 0.84 cases/
1000 farms in 50% of these provinces.Figure 1 shows the distribution by province of the
standardized incidence rates in the 8 regions where
the vaccine circulated: the provinces with the highest
risk of the disease are concentrated in central Italy, Sicily
and Sardinia.
Figure 2 illustrates the distribution by province of the
number of farms that had directly purchased the vaccine
from the manufacturer between November 1994 and
December 1996 in the 8 regions: most of the provinces
where an elevated number of farms purchased the vac-
cine are concentrated in central Italy. In 29 of the 45
provinces at least one farm had directly bought the vac-
cine. In 50% of the 29 provinces less than 6 farms had
purchased the vaccine (range: 1–18). In 16 provinces
the vaccine was also distributed by one or more retailers
or veterinarians.
As both the exposure variables (i.e. categorization of
the number of veterinarians or retailers who had pur-
chased the vaccine and categorization of the number
of farms that had bought the vaccine) showed a sig-
nificant association at the univariate analysis, they
were considered as potential risk factors (Table 2) to
be entered into the subsequent regression models.
Even the median farm size per province was statisti-
cally significant in the preliminary analysis; however,
when included in the final models, it didn't have
an impact on the effect of the other variables (data
not shown).
Tables 3 shows the results of the Poisson regression
models fitted to assess the association between the inci-
dence of the disease and the exposure level to the vac-
cine at the provincial level.
Model 1 included as independent variables the three
categories of the number of farms (by province) that had
purchased the vaccine. The incidence rate ratios (IRR)
indicate a rise in the risk of the disease as the number of
vaccine purchaser farms increases, with a 4-fold risk for
level 3 (provinces where at least 10 farms had bought
the vaccine). The goodness of fit of this model was bet-
ter than that of the same model in which we used fixed
effects, as shown by AIC values of 133.8 and 140.1,
respectively, showing a significant random effect for
the region.
Model 2 included as covariates both the three categor-
ies of the number of vaccine purchaser farms and the
two categories of the number of veterinarians or retailers
who had purchased the vaccine.
The Wald test to verify the statistical significance of
the linear regression coefficient was significant in both
models, evidencing a linear dose-response trend between
the number of farms that had bought the vaccine and
the disease incidence levels (model 1: Wald chi-square =
10.6, P value = 0.001; model 2: Wald chi-square = 14.3,
P value = 0.0008).
Figure 1 Standardized incidence rates in the provinces of the regions where the vaccine circulated (quartile). The provinces
characterized by the highest risk of disease are concentrated in central Italy, Sicily and Sardinia.
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1 veterinarian or retailer had bought the vaccine as own
stock is higher than the risk in the provinces where 0 or
1 bought it; however, the difference was not statistically
significant (95% CI: 0.91 - 4.1).
Again, the comparison of the AIC of the fixed-effects
model with the AIC of the mixed-effects model showed a
significant random effect of the region (136.1 vs 132.9).
Model 3 and model 4 were fitted by modelling the dir-
ect standardized incidence rates. As in the case of model
1, model 3 included as an independent variable only the
three categories of the number of farms (by province)
that had purchased the vaccine. The incidence rate
ratios (IRR) indicate that, with the increasing number of
vaccine purchaser farms, the risk of the disease also
increases.
As for model 2, the two categories of the number of
veterinarians or retailers who had purchased the vaccinewere entered into model 4 as a covariate. Again, there
was an upward trend in the risk with the increasing
number of farms per province that had purchased the
vaccine. The risk in the provinces where more than 1
veterinarian or retailer had bought the vaccine as own
stock was higher than the risk in the other provinces,
however, the difference was not statistically significant.
For both models, the AIC value of the mixed-effect
models was higher than the AIC value of the fixed-
effects models (model 3: 116.3 vs 114.3; model 4: 116.0
vs 114.0).
The Wald test of the linear regression coefficient to
check for the dose-response relationship between the
three levels of vaccine exposure and scrapie incidence
was 4.36 (chi-square = 0.036) for model 3 and 5.47 (chi-
square 0.065) for model 4.
Finally, the population attributable fraction estimated
for the number of expected cases obtained by direct
Figure 2 Distribution of the number of purchaser farms in the eight Italian regions (quartile). The map shows the distribution of the
number of farms that had bought the vaccine directly from the manufacturer between November 1994 and December 1996 in each province.
Most of the provinces where an elevated number of farms had purchased the vaccine are concentrated in central Italy.
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two-thirds of the outbreaks observed in the study area
between 2002 and 2005 might be attributable to an in-
direct exposure to the vaccine.
Discussion
The findings of this study show a heterogeneous distri-
bution of scrapie incidence in the Italian provinces be-
tween 2002 and 2005, even after standardization to
account for surveillance heterogeneity. The results of the
regression models suggest that some of these differences
are related to the long-term effect of the circulation of a
vaccine against contagious agalactia. This is also consist-
ent with a linear trend, i.e., a dose-response relationship
between the vaccine exposure level (number of farms
that had purchased the vaccine) and the level of crudeand adjusted incidence of disease. The results suggest
that the effect of the vaccine is statistically significant
when a large number of farms per province bought it.
Finally, the very high population attributable fraction
indicates that the indirect impact of vaccine circulation
on the spread of scrapie within the Italian small rumin-
ant population has been relevant in terms of secondary
outbreaks likely due to the exchange of animals from
directly exposed flocks.
An important aspect in epidemiological studies is the
evaluation of the spatial distribution of infectious dis-
eases because it allows potentially influencing factors to
be identified. When we want to compare different geo-
graphical areas, we need to choose judiciously among
the criteria for selecting outbreaks and exposed popula-
tions. In scrapie, for instance, outbreak notification relies








(new cases per 1000 farms) (95%CI)
Categorization of the
number of vets or retailers
who had bought the vaccine
1
(0-1vet or retailer)
71 216 47 0.66 Referent
2
(>1 vet or retailer)
7247 10 1.4 2.1
(1.1-4.1)
Categorization of the
number of farms that
had bought the vaccine
1
(0–4 farms)
49 849 25 0.50 (*) Referent
2
(5–10 farms)




7793 15 1.9 (*) 3.8
(2.0-7.3)
Herd size
(median for each province)
78 463 57 1.005
(1.001-1.01)
Both exposure variables related to the vaccine [(1) categorization of the number of veterinarians or retailers who had purchased the vaccine and (2)
categorization of the number of farms that had bought the vaccine] show a significant association with disease levels. The categorization of the number of farms
that had bought the vaccine shows a statistically significant upward trend in risk. The median farm size for each province resulted as not having a health impact
on the disease risk.
(*) Test for trend: χ2= 2.92, P value = 0.003.
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been integrated in European countries since 2002. In
this study we decided to not include outbreaks notified
by passive surveillance because under this system the de-
cision whether or not to include or exclude an individual
animal is not under the direct control of the veterinary
authorities [31]. This, in turn, can lead to underreporting
of disease occurrence [18] and to differences in surveil-
lance sensitivity in different regions.
Active surveillance coverage holds an important role in
disease control and its uneven application in the field may
influence the probability of case detection when a disease
is present. It's possible to correct for this heterogeneity,
however, by considering both the total number of animals
tested for each holding and their risk category. Several
studies evaluating surveillance systems and their effective-
ness in public health [32-34] have highlighted their import-
ance and complexity: to address this issue, we applied
classical standardization techniques to obtain comparable
incidence rates at the geographical level.
When we compared the geographical crude incidence
rates, we found a regional effect on the disease distribu-
tion. This effect was no longer evident when we applied
the same model to the adjusted incidence rates, suggest-
ing that the regional effect may be connected to the ap-
plied surveillance sensitivity, which was already included
in models 3 and 4 using the standardized data.A potential source of bias in our study may be the lack
of a complete database of the farms that had been
exposed to the vaccine. Reconstructing the actual vac-
cine commercial circuit was challenging. The lists of the
vaccine purchaser farms and of the seller veterinarians
that were used as proxy for exposure may have been in-
complete, resulting in an underestimation of the true
circulation of the vaccine. On the basis of the number of
vaccinated flocks in each province, we assumed that all
the flocks in a given province had experienced similar
exposure. Accordingly, we used average exposure levels
rather than actual individual values, as is frequently done
in geographical studies when the ecological fallacy is
possible [35]. In both cases, however, it's unlikely that
the direction of the observed impact of the vaccine on
the disease distribution would have been cancelled or
reversed if our data had been more complete.
The models we fitted allowed, for the first time, the
quantification of the disease risk associated with the vac-
cine circulation also for the farms that were only indir-
ectly exposed to it. Moreover, the estimated population
attributable fraction proved a good indicator of the real
impact on the entire population of vaccination. The use
of this measure of association in public health can be
very useful, since it allows the quantification of the cases
of disease that could have been avoided after eliminating
the exposure to the risk factor [29,30,36].
Table 3 Results of the mixed-effects Poisson regression models comparing incidence rates of outbreaks
Mixed effect model Covariate Exposure level IRR 95%CI AIC
(fixed effects model AIC)
1 Categorization of the number of farms
by province that had bought the vaccine
1 133.8
(based on modelling of
crude incidence rates)
(0-4 farms) Referent (140.1)
2 1.4 0.70, 2.7
(5-10 farms)
3 4.0 1.9, 8.6
(>10 farms)
2 Categorization of the number of farms by
province that had bought the vaccine
1
(based on modelling of
crude incidence rates)
(0-4 farms) Referent 132.9
2 1.3 0.66, 2.6 (136.1)
(5-10 farms)
3 3.6 1.7 , 7.5
(>10 farms)
Categorization of the number of vets or
retailers by province who had bought
the vaccine
1
(0-1 vet or retailer) Referent
2 1.9 0 .91, 4.1
(>1 vet or retailer)
3 Categorization of the number of farms by
province that had bought the vaccine
1 116.3
(based on modelling of
standardized incidence rates)
(0-4 farms) Referent (114.3)
2 1.3 0.56, 2.9
(5-10 farms)
3 2.7 1.1, 6.5
(>10 farms)
4 Categorization of the number of farms by
province that had bought the vaccine
1 116.0
(based on modelling of
standardized incidence rates)
(0-4 farms) Referent (114.0)
2 1.2 0.51, 2.6
(5-10 farms)
3 2.6 1.1, 6.4
(>10 farms)
Categorization of the number of vets or
retailers by province who had bought
the vaccine
1
(0-1 vet or retailer) Referent
2 1.8 0.71, 4.7
(>1 vet or retailer)
AIC =Akaike Information Criterion. IRR = incidence rate ratios (IRR) indicating the increase in the risk of the disease with, respectively, the increasing number of
vaccine purchaser farms or the increasing of veterinarians or retailers who had purchased the vaccine, per province. The AIC values in brackets refer to fixed-effect
models based on the same covariates.
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that we obtained may explain the scrapie incidence
levels observed in the study area so far. However, it can-
not completely account for the current risk of infection
for the farms located in the provinces considered be-
cause other local factors will have inevitably influenced
the epidemiology of the disease in the ensuing years.
The vaccine’s impact on the secondary outbreaks can
be explained by the presence of additional risk factorswhich, in general, contribute to the spread of the disease,
foremost of which is the exchange of live animals from
directly exposed farms. It might be interesting to quan-
tify the different degrees of the movement of live ani-
mals in different provinces. To do this, however, each
animal would need to be individually identifiable, and
such information is not currently available for sheep and
goats. Furthermore, animal exchange or genetic suscep-
tibility is unlikely to have acted as a confounding factor
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linked to exposure to the vaccine.
In conclusion, with this study we were able to quantify
an important long-term impact of the vaccine accident,
even if the number of directly exposed farms was lim-
ited. Our study shows that a large proportion of the
scrapie outbreaks, which occurred in the provinces
exposed to a vaccine against contagious agalactia in
1997, can be explained by exposure. Therefore, relevant
long-term consequences for scrapie incidence may be
expected if a vaccine accident occurs. With the use of
standardization techniques we can rule out a bias due to
differences in surveillance sensitivity.
Beyond the effect of the vaccine, the heterogeneous
distribution of scrapie in Italy deserves further research
to identify local risk factors for properly assessing the ef-
fectiveness of the national control strategy of scrapie,
which is largely based on the genetic selection
programme.Endnotes
a These data were aggregated at the provincial level.
The territory was subdivided into provincial administra-
tive units with their relative codes according to the 2005
data from the National Institute of Statistics [22].
Abbreviations
TSE: Transmissible spongiform encephalopathies; IRR: Tncidence rate ratio;
CI: Confidence interval.
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